about
Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?Apoptosis as a tool for therapeutic agents in haematological diseases.Cell survival and apoptosis signaling as therapeutic target for cancer: marine bioactive compounds.Mutations within the 5' region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma.Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape.
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
CD95 antigen mutations in hematopoietic malignancies.
@ast
CD95 antigen mutations in hematopoietic malignancies.
@en
CD95 antigen mutations in hematopoietic malignancies.
@nl
type
label
CD95 antigen mutations in hematopoietic malignancies.
@ast
CD95 antigen mutations in hematopoietic malignancies.
@en
CD95 antigen mutations in hematopoietic malignancies.
@nl
prefLabel
CD95 antigen mutations in hematopoietic malignancies.
@ast
CD95 antigen mutations in hematopoietic malignancies.
@en
CD95 antigen mutations in hematopoietic malignancies.
@nl
P2093
P2860
P1433
P1476
CD95 antigen mutations in hematopoietic malignancies.
@en
P2093
Buyuksal I
Goldstein S
Landowski TH
Moscinski L
Painter JS
P2860
P304
P356
10.3109/10428190109097702
P577
2001-09-01T00:00:00Z